← Eichor
Study identifier: NCT07187206 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Safety and Efficacy of FETO in CDH Phase III

Condition: Congenital Diaphragmatic Hernia · Pulmonary Hypoplasia · Pulmonary Hypertension  ·  Sponsor: Children's Hospital Medical Center, Cincinnati

PhasePhase 3
Planned participants75
Who can joinFemale, 18 Years to 50 Years
Healthy volunteersYes

About this study

Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group

This description comes directly from the study's public registry record.

Talk to the study team

Foong-Yen Lim, MD  ·  (513) 636-6259  ·  Foong-Yen.Lim@cchmc.org

Always discuss trial participation with your own doctor first.

Locations (1)

Cincinnati Children's Hospital Medical Center (CCHMC)Cincinnati, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07187206